| scholarly article | Q13442814 |
| P50 | author | Ning Qiao | Q89452628 |
| P2093 | author name string | Yang Chen | |
| Hao Zhang | |||
| Ying Zhu | |||
| Linghuan Gao | |||
| P2860 | cites work | Effect of hydrogen bonding interactions on the release mechanism of felodipine from nanodispersions with polyvinylpyrrolidone | Q31039504 |
| Physical stabilisation of amorphous ketoconazole in solid dispersions with polyvinylpyrrolidone K25. | Q31674692 | ||
| Use of a glutaric acid cocrystal to improve oral bioavailability of a low solubility API. | Q33249551 | ||
| Pharmaceutical co-crystals | Q34489354 | ||
| Enhancing the bioavailability of magnolol in rabbits using melting solid dispersion with polyvinylpyrrolidone. | Q34569875 | ||
| Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates | Q36863314 | ||
| Polymorphism in Carbamazepine Cocrystals | Q37157334 | ||
| The role of cocrystals in pharmaceutical science | Q37158713 | ||
| Pharmaceutical Cocrystals and Their Physicochemical Properties | Q37510600 | ||
| Pharmaceutical cocrystals: an overview | Q37914361 | ||
| Influence of sodium lauryl sulfate and tween 80 on carbamazepine-nicotinamide cocrystal solubility and dissolution behaviour | Q41869235 | ||
| Polymorph screening: influence of solvents on the rate of solvent-mediated polymorphic transformation | Q43824769 | ||
| Engineering cocrystal solubility, stability, and pH(max) by micellar solubilization | Q84936529 | ||
| Investigating the Influence of Polymers on Supersaturated Flufenamic Acid Cocrystal Solutions | Q88066595 | ||
| In situ monitoring of carbamazepine-nicotinamide cocrystal intrinsic dissolution behaviour | Q44130485 | ||
| Polyvinylpyrrolidone-drug conjugate: synthesis and release mechanism | Q44698552 | ||
| Solvent-drop grinding: green polymorph control of cocrystallisation | Q44815137 | ||
| Stability and solubility of celecoxib-PVP amorphous dispersions: a molecular perspective | Q45155831 | ||
| Anti-solvent co-crystallization of carbamazepine and saccharin. | Q46353187 | ||
| Neuropsychological functioning in methadone maintenance patients versus abstinent heroin abusers | Q46489623 | ||
| Influence of polymeric excipients on crystal hydrate formation kinetics in aqueous slurries | Q46616963 | ||
| Crystallization pathways and kinetics of carbamazepine-nicotinamide cocrystals from the amorphous state by in situ thermomicroscopy, spectroscopy, and calorimetry studies | Q48404086 | ||
| Recent Advances in Understanding the Mechanism of Cocrystal Formation via Grinding | Q56769806 | ||
| Applying Hot-Stage Microscopy to Co-Crystal Screening: A Study of Nicotinamide with Seven Active Pharmaceutical Ingredients | Q57966858 | ||
| Formation Kinetics and Stability of Carbamazepine−Nicotinamide Cocrystals Prepared by Mechanical Activation | Q59234848 | ||
| Study of possible complex formation between macromolecules and certain pharmaceuticals. II. Polyvinylpyrrolidone with p-aminobenzoic acid, aminopyrine, benzoic acid, salicylic acid, p-hydroxybenzoic acid, m-hydroxybenzoic acid, citric acid, and phen | Q73562878 | ||
| Improving the chemical stability of amorphous solid dispersion with cocrystal technique by hot melt extrusion | Q82085136 | ||
| Physicochemical and mechanical properties of carbamazepine cocrystals with saccharin | Q83294512 | ||
| Reaction crystallization of pharmaceutical molecular complexes | Q83913212 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 4 | |
| P921 | main subject | cocrystal | Q5139913 |
| P577 | publication date | 2017-12-01 | |
| P1433 | published in | Pharmaceutics | Q27723332 |
| P1476 | title | Preparation and Characterization of Cabamazepine Cocrystal in Polymer Solution | |
| P478 | volume | 9 |
Search more.